HCA Healthcare Quote - H1CA34 | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Brazil
BOV
HCA Healthcare Inc (H1CA34) Share Price

HCA Healthcare Inc (H1CA34)

95.49

1.14

(1.21%)

Closed November 26 2:55PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

95.49

Bid

0.00

Ask

0.00

Volume

20

95.49 Day's Range 95.49

60.06 52 Week Range 118.68

Market Cap

Previous Close

94.35

Open

95.49

Last Trade

Last Trade Time

Financial Volume

R$ 1,910

VWAP

95.49

Average Volume (3m)

1,366

Shares Outstanding

267,661,000

Dividend Yield

0.55%

PE Ratio

16.80

Earnings Per Share (EPS)

19.58

Revenue

64.97B

Net Profit

5.24B

Sector

Gen Med & Surgical Hospitals

Industry

Gen Med & Surgical Hospitals

Website

www.hcahealthcare.com

Headquarters

Wilmington, Delaware, USA

Founded

-

HCA Healthcare Inc is listed in the Gen Med & Surgical Hospitals sector of the Brazil Bovespa Exchange with ticker H1CA34. The last closing price for HCA Healthcare was R$94.35. Over the last year, HCA Healthcare shares have traded in a share price range of R$ 60.06 to R$ 118.68.

HCA Healthcare currently has 267,661,000 shares outstanding. The market capitalization of HCA Healthcare is R$25.25 billion. HCA Healthcare has a price to earnings ratio (PE ratio) of 16.80.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.81	-1.86022610483	97.3	97.3	92.05	1469	94.36448264	DR
4	-8.11	-7.82818532819	103.6	105.38	92.05	1493	100.21280337	DR
12	-16.16	-14.47380206	111.65	118.68	92.05	1366	105.36646297	DR
26	10.13	11.8673851921	85.36	118.68	84.64	1332	98.62523472	DR
52	33.69	54.5145631068	61.8	118.68	60.06	894	93.99657942	DR
156	30.63399903	47.2338697604	64.85600097	118.68	43.65400065	865	74.42788396	DR
260	63.17199952	195.470012321	32.31800048	118.68	16.30000024	725	69.6749738	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MWET4Wetzel Sa (ex Metalurgica Wetzel Sa)	R$ 17.01 (30.85%)	11k
PPLA11PPLA Participations Ltd	R$ 2.25 (15.38%)	823
BHIA3Grupo Casas Bahia SA	R$ 4.09 (11.14%)	6.53M
BRAV3Brava Energia	R$ 20.86 (9.33%)	19.3M
VIVR3Viver Incorporadora e Construtora SA	R$ 1.43 (9.16%)	277k
RPAD3Alfa Holdings Sa (ex Real Sa Participacoes Administracao)	R$ 6.75 (-14.99%)	1.2k
ATOM3Atom Empreendimentos e Participacoes SA	R$ 4.19 (-10.47%)	342.7k
OSXB3OSX Brasil SA	R$ 3.96 (-8.97%)	27.3k
IFCM3Infracommerce Caxaas S.A.	R$ 0.11 (-8.33%)	1.87M
TRAD3TC S.A.	R$ 6.80 (-6.85%)	143.1k
COGN3CognaEducacao SA	R$ 1.47 (2.08%)	57.05M
HAPV3Hapvida Participacoes Investimento SA	R$ 3.05 (0.99%)	50.75M
CVCB3CVC Brasil Operadora E Agencia De Viagens SA	R$ 2.84 (3.27%)	44.95M
MGLU3Magaz Luiza	R$ 10.64 (6.29%)	36.38M
OIBR3Oi	R$ 1.69 (7.64%)	35.24M

RickNagra

RickNagra 4 minutes ago

Wrong. Look again carefully. I recommend zooming in. It says com and not con.

BamaBreeze

BamaBreeze 8 minutes ago

The management would stand to make A lot of money. More than cheating shareholders out of theirs. That would be a major incentive I would think.

jondoeuk

jondoeuk 9 minutes ago

A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr

gfp927z

gfp927z 9 minutes ago

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barron's

by Paul R. La Monica

Nov 22, 2024

https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2

dinogreeves

dinogreeves 11 minutes ago

Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i

bluebird50

bluebird50 11 minutes ago

Guess crows don't like coffee.... delete this post and Crows...

;-) so we don't witness a murder... a group of crows... Che Che Che

BamaBreeze

BamaBreeze 11 minutes ago

Good on you!! Bless us.

ducci1

ducci1 11 minutes ago

Pivot Calcs: SPX Pivot--6012----R1--6033----R2--6045----S1--6000----S2--5980-----SPY Pivot--599----R1--601----R2--602----S1--598----S2--596-----VIX Pivot--14.33 !!LOL!!

imnot6

imnot6 12 minutes ago

Well, extended duration is their value proposition...

JohnnyHydrogen

JohnnyHydrogen 12 minutes ago

AI Czar ?

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk

....

"The office would spur the massive private investment needed to expand the energy supply to keep the U.S. on the cutting edge."

gfp927z

gfp927z 13 minutes ago

Bigworld, Here's more info relating to Acurx's recent move to buy some Bitcoin (below). So far that boneheaded decision by Luci has cut Acurx's share price nearly in half -

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

gfp927z

gfp927z 18 minutes ago

Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Barron's

by Paul R. La Monica

Nov 22, 2024

https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2

Mountainman5

Mountainman5 18 minutes ago

Red Cat & OPT = WinWin!!!!!!!!!!!!!

BDEZ

BDEZ 19 minutes ago

Thanks georgie..

$GROO

$GROO 20 minutes ago

Never Quit $SANP
Never Quit $SANP $GROO ht

Oleblue

Oleblue 20 minutes ago

In this solo lecture, Chris Miller, author of the acclaimed book "Chip War", delves into the intricate world of semiconductors, exploring how microchips have become the cornerstone of global power and economic influence. Miller will provide an analysis of the geopolitical ramifications of semiconduc

JettaR

JettaR 22 minutes ago

No one is "rooting" for the stock to go down. Eyes wide open. Eyes wide open. It's right on front of everyone.

lambchops

lambchops 22 minutes ago

Peeps ought to gobble up some NFTM shares for gobble-gobble day!

Eat turkey--not lamb-- on Christmas! Yum-yum.

Happy T-bird day. And remember,"Fun. Fun, fun till your daddy takes the T-bird awayNFTM

reaper247

reaper247 24 minutes ago

Always good to hear from ya Drugdoctor.

I suspect we have a few people lurking around.

Hope all GVSIers have as safe and happy Thanksgiving.

GLTA, IMO and FWIW.

jondoeuk

jondoeuk 24 minutes ago

One for FT819 as well https://www.globenewswire.com/news-release/2024/11/18/2982757/24675/en/Fate-Therapeutics-Presents-6-Month-Follow-up-Data-on-First-Patient-Treated-in-Phase-1-Autoimmunity-Study-with-Fludarabine-free-Conditioning-and-FT819-Off-the-shelf-1XX-CAR-T-cell-P.html

skitahoe

skitahoe 25 minutes ago

NWBO is in a similar situation in the EU. I believe that you'll find that the 150 days doesn't begin with submission. No one is absolutely certain, some believed it started with preliminary validation, which occurred roughly a month after submission. Others believed it began with final validation

jjjjjjjj

jjjjjjjj 25 minutes ago

Gummies for dummies -- yummies , LMAO burger flipper
Reply privately from blusher.

Keep doing the 2 steps:
1. SET SELL HIGH our shares.
2. SET BUY HIGHssssssss with last minute and price limit.

MJNA is a good company. Best to us longs.

jondoeuk

jondoeuk 25 minutes ago

The PR https://www.globenewswire.com/news-release/2024/11/18/2982736/24675/en/Fate-Therapeutics-Highlights-FT522-Off-the-shelf-ADR-armed-CAR-NK-Cell-Product-Candidate-at-2024-ACR-Convergence.html

gfp927z

gfp927z 27 minutes ago

Xena, All I said was that a B-12 deficiency might be the cause of your advancing foot numbness. Gadolinium toxicity might have the same effect (?), but logic says to eliminate other obvious possibilities before concluding that it is the gadolinium.

>> given the level of supplementa

jondoeuk

jondoeuk 27 minutes ago

They need to pick up the pace of enrolment. If they don't see activity at DL2, I think it could be in trouble.

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions